AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Tvorogova, MG
Citation: Mg. Tvorogova, Reverse cholesterol transport, KARDIOLOGIY, 41(2), 2001, pp. 66-72

Authors: Kozlov, SG Lyakishev, AA Tvorogova, MG
Citation: Sg. Kozlov et al., Assessment of efficacy of fluvastatin and fenofibrate in patients with noninsulin-dependent diabetes with hypercholesterolemia and combined hyperlipidemia, KARDIOLOGIY, 40(5), 2000, pp. 4-9

Authors: Solovyeva, EY Rozhkova, TA Tvorogova, MG Kukharchuk, VV
Citation: Ey. Solovyeva et al., Cerivastatin - A new synthetic 3-hydroxy-3-methylglutaryl (HMG) inhibitor:Effect of 0.2 mg dose in patients with primary hyperlipidemias, TERAPEVT AR, 71(8), 1999, pp. 30-34

Authors: Susekov, AV Tvorogova, MG Arabidze, GG Kukharchuk, VV
Citation: Av. Susekov et al., Lipanor treatment of atherogenic hyperlipoproteinemia, TERAPEVT AR, 70(9), 1998, pp. 57-61

Authors: Tvorogova, MG Susekov, AV Semenova, OA Kukharchuk, VV Titov, VN
Citation: Mg. Tvorogova et al., Factors of renal disease progress and probability of regulating these factors in principle, TERAPEVT AR, 70(12), 1998, pp. 5-8

Authors: Tvorogova, MG Susekov, AV Semenova, OA Kukharchuk, VV Titov, VN
Citation: Mg. Tvorogova et al., Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia, TERAPEVT AR, 70(12), 1998, pp. 8-13

Authors: Korotaeva, AA Golovanova, NK Vlasik, TN Yanushevskaya, EV Tsibulsky, VP Yakushkin, VV Tvorogova, MG Morozkin, AD Prokazova, NV
Citation: Aa. Korotaeva et al., Immunoreactivity of apolipoprotein B-100 and binding to LDL-receptor of phospholipase A(2)-treated low density lipoproteins, BIOCHEM-MOS, 63(12), 1998, pp. 1430-1437
Risultati: 1-7 |